NASDAQ: VIGL
Vigil Neuroscience Inc Stock Ownership - Who owns Vigil Neuroscience?

Insider buying vs selling

Have Vigil Neuroscience Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Haeberlein Samantha L. BuddDirector2024-12-1912,000$1.71
$20.52kBuy
Ivana MagovcevicliebischPresident and CEO2024-12-195,000$1.68
$8.40kBuy
Ivana MagovcevicliebischPresident and CEO2024-12-185,000$1.67
$8.35kBuy
Ivana MagovcevicliebischPresident and CEO2024-12-055,000$2.34
$11.70kBuy

1 of 1

VIGL insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when VIGL insiders and whales buy or sell their stock.

VIGL Shareholders

What type of owners hold Vigil Neuroscience Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Atlas Venture Fund XII LP12.51%5,836,874$9.98MInsider
Atlas Venture Life Science Advisors LLC12.51%5,836,874$9.98MInstitution
Bruce Booth12.51%5,836,874$9.98MInsider
Stefan Vitorovic10.77%5,027,465$8.60MInsider
Vida Ventures GP III LLC10.75%5,015,929$8.58MInsider
Northpond Ventures GP LLC9.03%4,214,498$7.21MInsider
Amgen Inc6.87%3,206,281$5.48MInsider
Siren LLC4.27%1,991,038$3.40MInstitution
Bvf Inc3.89%1,813,633$3.10MInstitution
Clay Thorp3.34%1,559,030$2.67MInsider

1 of 3

VIGL vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
VIGL41.59%58.41%Net Buying
EPIX73.96%11.07%Net Selling
ACHV47.11%27.59%Net BuyingNet Buying
CRBP46.25%53.75%Net BuyingNet Selling
SGMT44.49%55.51%Net Selling

Vigil Neuroscience Stock Ownership FAQ

Who owns Vigil Neuroscience?

Vigil Neuroscience (NASDAQ: VIGL) is owned by 48.45% institutional shareholders, 68.04% Vigil Neuroscience insiders, and 0.00% retail investors. Atlas Venture Fund XII LP is the largest individual Vigil Neuroscience shareholder, owning 5.84M shares representing 12.51% of the company. Atlas Venture Fund XII LP's Vigil Neuroscience shares are currently valued at $9.81M.

If you're new to stock investing, here's how to buy Vigil Neuroscience stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.